Found 21 HIV trials
A listing of HIV medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This phase II trial studies the side effects of chemotherapy and intensity modulated radiation therapy in treating patients with low-risk HIV-associated anal cancer, and nivolumab after standard of care chemotherapy and radiation therapy in treating patients with high-risk HIV-associated anal cancer.
The purpose of this study is to look at where human immunodeficiency virus (HIV) might be “hiding” when standard lab tests show that HIV levels in the blood are very low.
The main purpose of this study is to try a new type of laboratory test for COVID-19 (also called SARS-CoV-2 or novel coronavirus). COVID-19 is a new disease, so not enough is known about it yet. This study hopes to collect more information about who is most as risk from …
The purpose of this study is to study how well patients that receive a kidney from an HIV+ organ donor do over 10 years compared to patients that receive a kidney from an HIV- donor. People 18 years of age and older with end-stage renal disease and HIV, and who …
This study is being done to try to answer questions about the ways that HIV infection is sometimes well controlled over time.
The research study is being conducted to examine the effects of personalized smoking cessation medication treatment in order to help people with HIV/AIDS to quit smoking. During the study, participants will take either varenicline (brand name Chantix®) or use the nicotine patch, and they will receive smoking cessation therapy with …
This study will investigate whether N-803, a new experimental drug that stimulates the immune system, is safe and tolerable when given alone and in combination with two new experimental drugs that are antibodies (natural proteins that the body makes in response to an infection) to HIV (the virus that causes …
This study will assess the safety, tolerability, pharmacokinetics, and antiviral activity of long-acting cabotegravir (CAB LA) plus the broadly neutralizing monoclonal antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), in adults living with HIV-1 with suppressed plasma viremia.
The purpose of this study is to partner with patients to understand how to best treat the mental health and substance use needs of individuals living with HIV who receive care at Penn Medicine. Participating in this study involves a one-time interview. During the interview, a researcher will ask you …
The objective of this study is to complete a pre-implementation inquiry at RHD to assess barrier and facilitators to implementing a new intervention and assess awareness, acceptability and knowledge of HIV prevention modalities like PrEP among staff and residents. Narrative summaries will be generated for each participant, using transcripts and …
